Go offline with the Player FM app!
🧪🛡️ Stroke Shield: How Tirofiban Tips the Scales
Manage episode 493334231 series 2740117
🧠✨ New Stroke Breakthrough!
The ASSET-IT trial shows that early infusion of tirofiban after thrombolysis significantly boosts recovery in noncardioembolic stroke patients — with 65.9% achieving excellent outcomes at 90 days vs 54.9% with placebo 📈💉
✅ Improved function
⚠️ Slightly higher bleeding risk
🌏 Study conducted across 38 centers in China
📚 Read the trial in NEJM (July 2025)
#Stroke #Tirofiban #Neurology #RCT #PrecisionMedicine #Thrombolysis #CardiovascularResearch
564 episodes
Manage episode 493334231 series 2740117
🧠✨ New Stroke Breakthrough!
The ASSET-IT trial shows that early infusion of tirofiban after thrombolysis significantly boosts recovery in noncardioembolic stroke patients — with 65.9% achieving excellent outcomes at 90 days vs 54.9% with placebo 📈💉
✅ Improved function
⚠️ Slightly higher bleeding risk
🌏 Study conducted across 38 centers in China
📚 Read the trial in NEJM (July 2025)
#Stroke #Tirofiban #Neurology #RCT #PrecisionMedicine #Thrombolysis #CardiovascularResearch
564 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.